ARTICLE | Distillery Therapeutics
Gastrointestinal
March 21, 2017 3:21 PM UTC
In vitro and mouse studies identified a chlorobenzamide-based inhibitor of bromodomain 1 of BET bromodomain proteins that could help treat colitis. Structure-based design, chemical synthesis and in vi...
BCIQ Company Profiles